Gastroenterology and hepatology

Leuven researchers have discovered that stomach problems are often linked to an inflamation of the first part of the small intestine. The degree of inflammation is considered to be a new biomarker that can help reach the right diagnosis. At the same time it is an important starting point for better treatments.

Patients that go to their GP with symptoms of the irritable bowel syndrome can be helped more than adequately with special diet, as shown by an UZ Leuven trial. The results lead to a new recommendation for the follow-up of irritable bowel syndrome via GPs.

KU Leuven researchers have identified the biological mechanism that explains why some people experience abdominal pain when they eat certain foods. The finding paves the way for more efficient treatment of irritable bowel syndrome and other food intolerances.